In testimony presented to a US House of Representatives Judiciary subcommittee the Federal Trade Commission described its ongoing efforts to promote competition that benefits consumers and businesses in key sectors of the economy.
Testifying on behalf of the FTC before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law, Chairwoman Edith Ramirez said that “for more than 100 years now, the Commission has worked to ensure that American markets are open, vibrant, and unencumbered by unreasonable private or public restraints.”
The testimony indicates that in FY 2014 and through the first half of FY 2015, the agency challenged 28 mergers. In most, it negotiated a remedy allowing the merger to proceed. But in three instances, the parties abandoned the deal after the FTC raised concerns, and in three other cases, the Commission authorized staff to stop the merger. One of those is the pending preliminary injunction action to block the proposed merger between Sysco Corporation and US Foods. The FTC alleges that the proposed Sysco/US Foods merger will lead to higher prices and reduced service for national customers as well as customers in 32 local markets.
Additionally, the Commission continues to prioritize stopping anticompetitive mergers and conduct in healthcare markets, which threaten to undermine efforts to control costs, the testimony states.
Full content: Imperial Valley News
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas